Geneos Wealth Management’s Marvell Technology MRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.09M | Sell |
10,358
-3,789
| -27% | -$760K | 0.06% | 307 |
|
|
2026
Q1 | $1.4M | Buy |
14,147
+553
| +4% | +$46.4K | 0.03% | 426 |
|
|
2025
Q4 | $1.16M | Buy |
13,594
+1,147
| +9% | +$100K | 0.03% | 464 |
|
|
2025
Q3 | $1.05M | Sell |
12,447
-1,528
| -11% | -$112K | 0.03% | 476 |
|
|
2025
Q2 | $1.08M | Sell |
13,975
-864
| -6% | -$53.9K | 0.03% | 515 |
|
|
2025
Q1 | $914K | Buy |
14,839
+5,744
| +63% | +$557K | 0.03% | 477 |
|
|
2024
Q4 | $1M | Buy |
9,095
+5,791
| +175% | +$538K | 0.04% | 426 |
|
|
2024
Q3 | $238K | Sell |
3,304
-303
| -8% | -$20.9K | 0.01% | 727 |
|
|
2024
Q2 | $252K | Buy |
3,607
+90
| +3% | +$6.31K | 0.01% | 647 |
|
|
2024
Q1 | $249K | Sell |
3,517
-1,064
| -23% | -$72.9K | 0.01% | 647 |
|
|
2023
Q4 | $276K | Buy |
4,581
+1,677
| +58% | +$90.6K | 0.01% | 596 |
|
|
2023
Q3 | $157K | Buy |
2,904
+293
| +11% | +$17.3K | 0.01% | 743 |
|
|
2023
Q2 | $156K | Sell |
2,611
-1,360
| -34% | -$66.1K | 0.01% | 743 |
|
|
2023
Q1 | $172K | Buy |
3,971
+1,882
| +90% | +$79.3K | 0.01% | 688 |
|
|
2022
Q4 | $77.4K | Buy |
2,089
+1,067
| +104% | +$43.6K | ﹤0.01% | 903 |
|
|
2022
Q3 | $43K | Sell |
1,022
-829
| -45% | -$41K | ﹤0.01% | 1077 |
|
|
2022
Q2 | $78K | Sell |
1,851
-190
| -9% | -$10.8K | ﹤0.01% | 1103 |
|
|
2022
Q1 | $146K | Buy |
+2,041
| New | +$147K | 0.01% | 941 |
|
|
2021
Q2 | – | Sell |
-110
| Closed | -$4K | – | 3016 |
|
|
2021
Q1 | $4K | Sell |
110
-1,279
| -92% | -$62.7K | ﹤0.01% | 2724 |
|
|
2020
Q4 | $60K | Buy |
1,389
+383
| +38% | +$16.6K | ﹤0.01% | 1367 |
|
|
2020
Q3 | $38K | Sell |
1,006
-20
| -2% | -$736 | ﹤0.01% | 1367 |
|
|
2020
Q2 | $34K | Buy |
1,026
+20
| +2% | +$586 | ﹤0.01% | 1393 |
|
|
2020
Q1 | $22K | Buy |
1,006
+200
| +25% | +$4.79K | ﹤0.01% | 1472 |
|
|
2019
Q4 | $21K | Buy |
806
+1
| +0.1% | +$25 | ﹤0.01% | 1663 |
|
|
2019
Q3 | $19K | Hold |
805
| – | – | ﹤0.01% | 1633 |
|
|
2019
Q2 | $19K | Buy |
805
+400
| +99% | +$9.34K | ﹤0.01% | 1657 |
|
|
2019
Q1 | $8K | Hold |
405
| – | – | ﹤0.01% | 1909 |
|
|
2018
Q4 | $6K | Hold |
405
| – | – | ﹤0.01% | 1937 |
|
|
2018
Q3 | $7K | Buy |
405
+219
| +118% | +$4.5K | ﹤0.01% | 1972 |
|
|
2018
Q2 | $3K | Buy |
+186
| New | +$3.97K | ﹤0.01% | 2050 |
|
|
2017
Q2 | – | Sell |
-7,558
| Closed | -$115K | – | 2112 |
|
|
2017
Q1 | $115K | Hold |
7,558
| – | – | 0.01% | 623 |
|
|
2016
Q4 | $104K | Sell |
7,558
-20,469
| -73% | -$279K | 0.01% | 608 |
|
|
2016
Q3 | $371K | Hold |
28,027
| – | – | 0.05% | 302 |
|
|
2016
Q2 | $267K | Sell |
28,027
-14,088
| -33% | -$141K | 0.04% | 376 |
|
|
2016
Q1 | $418K | Buy |
+42,115
| New | +$388K | 0.06% | 266 |
|
Other funds holding MRVL
Geneos Wealth Management's MRVL Position: Q2 2026 in Review
Geneos Wealth Management reduced its Marvell Technology (MRVL) stake by 27% in Q2 2026, selling an estimated $760K and leaving 10,358 shares worth $3.09M. The position accounts for 0.06% of the portfolio, ranked #307.
Geneos Wealth Management first reported a position in MRVL in Q1 2016 and has held it in 35 quarters since. 2,224 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.
- Geneos Wealth Management held 10,358 shares of Marvell Technology worth $3.09M as of Q2 2026.
- Geneos Wealth Management sold 3,789 Marvell Technology shares in Q2 2026, an estimated $760K.
- Marvell Technology made up 0.06% of Geneos Wealth Management's portfolio in Q2 2026, its #307 holding.
- Geneos Wealth Management first reported a position in Marvell Technology in Q1 2016 and has held it in 35 quarters since.
- 2,224 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.